Fosun Pharmaceutical announced that its holding subsidiary Fosun Pharmaceutical Industries signed a “Cooperation and Choice Agreement” with Clavis Bio. According to the agreement, within the agreed cooperation period, Fosun Pharmaceutical Industries and Clavis Bio will jointly select targets and advance pre-clinical development of selected target compounds. Clavis Bio has the right to choose exclusive licenses for development, production and commercialization of such cooperative projects on a global scale other than within China, Hong Kong, and Macau.

Zhitongcaijing · 2d ago
Fosun Pharmaceutical announced that its holding subsidiary Fosun Pharmaceutical Industries signed a “Cooperation and Choice Agreement” with Clavis Bio. According to the agreement, within the agreed cooperation period, Fosun Pharmaceutical Industries and Clavis Bio will jointly select targets and advance pre-clinical development of selected target compounds. Clavis Bio has the right to choose exclusive licenses for development, production and commercialization of such cooperative projects on a global scale other than within China, Hong Kong, and Macau.